Clinical Trial

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-09-12; most recent amendment 2026-06-25.
Trial Details
NCT Number NCT07174349
Lead Sponsor Mayo Clinic
Conditions Urinary Retention Postoperative
Enrollment 20 participants
Start Date 2026-10-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-29